Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ·Healthcare·Biotechnology
$266.11
+4.32%
Mkt Cap $5.10B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (16 analysts)
$249.33
Range $230.00 – $275.00
Implied Upside
-6.3%
Consensus $249.33 vs current $266.11